Share this article
MONTVALE, N.J., Feb. 3, 2021 /PRNewswire/
EmpiRx Health, the industry s only value-based pharmacy benefit manager (PBM), today unveiled its pharmacogenomics (PGx) solution, designed to improve health outcomes and deliver increased value. Powered by
OneOme, a leading PGx solutions provider co-founded by Mayo Clinic, the offering leverages the science behind the role of genetics in drug interactions, strengthened by EmpiRx Health s population health management approach and complex care management services, to identify and support members who would benefit most from genetics-guided drug selection.
Twenty-nine percent of Americans take more than five medications and may benefit from PGx as gene variations play a significant role in drug metabolism and efficacy. In fact, 50% of drugs are ineffective or minimally effective in part due to gene variations, resulting in lost time and added costs for the patient. Additionally, absent an understanding of their genet